• Pharma
  • April 25, 2025
  • 175 views
Laurus Labs Q4 net surges to Rs 234 cr. on higher CDMO revenue

Drugmaker Laurus Labs reported consolidated net profit for the March quarter surged to ₹233.87 crore from ₹75.32 crore a year earlier on a 19% increase in the revenue. Revenue from…

  • Pharma
  • April 5, 2025
  • 384 views
Pharma Stocks Plunge on Trump Tariff Threat

New Delhi:  Shares of Pharmaceutical companies on Friday tumbled up to 10 per cent amid reports that the Trump Administration will soon announce tariffs on pharma imports and emphasised that…

  • Pharma
  • March 24, 2025
  • 453 views
SMS Pharma gains after Hyderabad facility completes USFDA inspection

SMS Pharmaceuticals rose 1.79% to Rs 221.80 after company announced that it has successfully completed a US Food and Drug Administration (USFDA) inspection at its API manufacturing facility located in…

  • Pharma
  • October 14, 2023
  • 373 views
CDSCO approves India’s first CAR-T cell therapy against certain blood cancers

ImmunoACT is an IIT Bombay incubated company-backed by drug maker Laurus Labs on Friday said it has received approval from Indian drug regulator the Central Drugs Standard Control Organization (CDSCO) for its…